Ignite Creation Date:
2024-05-05 @ 9:27 PM
Last Modification Date:
2024-10-26 @ 10:04 AM
Study NCT ID:
NCT00880711
Status:
COMPLETED
Last Update Posted:
2011-11-30
First Post:
2009-04-10
Brief Title:
Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer BC
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer
Status:
COMPLETED
Status Verified Date:
2011-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FIONA
Brief Summary:
The purpose is to collect real life data on the use of fulvestrant in normal clinical practice in Austria and document the clinical benefit of fulvestrant treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None